×
Credit: PROFESSOR JOHN ZAJICEK/Science Source
Welcome to The Multiple Sclerosis Journey. Join us for a multimedia exploration of where MS treatment and research stands, what the future of care may hold, and the experiences of clinicians and patients as they collaborate on the frontlines of MS care.
The Multiple Sclerosis Journey will examine new insights on the importance of early diagnosis as well as accurate identification of the four MS phenotypes and how their recognition impacts treatment selection. Join us as we examine the importance of maintaining brain health in sustaining wellness and ability among patients with MS. Experience discussions of the role of patient and physician collaboration in sustaining continuity of care and in tailoring therapy to individual patient needs and preferences.

And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.

The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.

Walk with us.

Featured Articles

Accident gives MS doctor insight into patients’ lives

As Gavin Giovannoni, MBBCh, PhD, an esteemed British multiple sclerosis (MS) expert, set out for his Saturday morning run on Nov. 7, 2020, the world’s weighty problems swirled through his head. Brexit, a U.S. election, a global pandemic, not to mention the daily struggles of his patients with their degenerative illness.

Possible cause of MS? How a gene variant can combine with environmental factors to cause MS

The distinct way immune cells respond to viruses like Epstein-Barr in people with the HLA-DR15 gene variant plays a significant role in the development of multiple sclerosis (MS), according to new research into what causes the autoimmune disease.

Gut cells linked to positive immune response in MS

Neuroinflammation appears to trigger gut cells to enhance levels of the antibody IgA and send it to the rescue via human spinal fluid, a new study finds. Researchers believe this insight could lead to advances in the diagnosis and treatment of multiple sclerosis (MS).

Two new potential therapies for MS hold promise as treatments in humans

Two experimental therapies being investigated for multiple sclerosis (MS) by researchers at Thomas Jefferson University, Philadelphia, may hold promise as eventual treatments for the disease.

Hookworm treatment to increase the immune response in patients with MS is a promising area of study

Promotion of hookworm infection may be an innovative future approach to improving immune response in patients with relapsing multiple sclerosis (MS), according to the results of a phase 2, randomized clinical trial.